SSPC News & Events

SSPC’s Carol McCarthy, UCC, is featured in the Evening Echo taking a closer look at science

Carol’s piece highlights the challenge poor water solubility poses for the development of many drug candidates and how her PhD research explores the application of mesoporous silica to overcome this challenge. She explains how many serious illnesses exist that have very limited medical treatments. Her research involves developing new types of tablets and capsules that will help solve this problem. Her findings to date and future research plans are to understand the mechanisms by which drug molecules are released into solution from the surface of the silica materials.

SSPC Scientific Director Prof. Kieran Hodnett will be featured speaker at BioPharmaAmbition 2016

biopharmaambition2016

The Irish Pharmaceutical Healthcare Association (IPHA) and BioPharma Chem Ireland (BPCI) representing the research based and manufacturing biopharmaceutical and chemical industries respectively, have come together with the National Institute for BioProcessing Research and Training to host BioPharma Ambition®, a multi-platform event to inspire and showcase innovation. The international convention will take place in Dublin on 21-22 September 2016.

SSPC co-sponsor Eighth pan-European QbD & PAT Science Conference in UCC

SSPC_PAT_promo

Inventing Tomorrow’s Development and Manufacturing
The Eighth pan-European Science Conference (EuPAT) on QbD and PAT Sciences brings together pharmaceutical scientists and engineers from industry, academia and regulatory agencies to discuss recent developments and future trends in the field of pharmaceutical product and process development. The 8th EuPAT conference will focus on PAT integration into pharmaceutical manufacturing, the biopharmaceutics risk assessment roadmap (BioRAM) for the integration of preclinical, clinical and pharmaceutical development including QbD for better products and QbD considerations for emerging therapies (biosimilars and nanomedicines).

SSPC Technical Meetings: Collaboration is the key to long-term business success and competitiveness

technical_collage

One of the key aims at SSPC is to enable productive participation and strategic partnerships with all stakeholders. Success relies on key efforts made by academia and the pharmaceutical industry working together. SSPC’s operations team helps facilitate such collaboration by conducting informal project evaluations, discussions and face-to-face meetings at quarterly technical meetings every year.

SSPC prides itself on being one of the very few centres who accommodate all partners to meet regularly and assess the interactions between, and the innovations of, each individual project and strand. By facilitating and coordinating the interaction between key stakeholders, engagement at this level nurtures opportunity. In addition, it offers frequent review of research and also a platform for students to attend and present their work.

(bio)Pharma Ireland make their case in Brussels

brussels_group

Engagement in EU Horizon 2020 programmes is of strategic importance to the Irish (bio)Pharma sector however there is currently a gap to bridge between discovery and manufacture to support scientific and engineering programmes. The SSPC, in an effort to push the (bio)Pharmaceutical manufacturing research priorities within the current EU Horizon 2020 programme, initiated a national collaborative working group with representation from industry, government and academia.

SSPC funded investigator Dr. Kevin Ryan wins MSSI, UL, research award for the most Web of Science journal papers published

kevin_m_ryan

The MSSI Research Award for most Web of Science journal papers with MSSI affiliation published in 2015 with impact factor greater than 1.5 was presented to Dr Kevin Ryan, who published 10 Web of Science papers with MSSI affiliation in journals with impact factor greater than 1.5.

Pages

Partner Logos - HE